AlphaOne Pharmaceuticals Inc., Dana-Farber Cancer Institute deal

AlphaOne acquired commercialization rights to the institute's maspin tumor suppressor gene, which encodes a serine protease inhibitor that AlphaOne said inhibited tumor growth and metastasis in anima...